The transcriptional differences between A549 with and without ACE2 would presumably have something to do with ACE2 receptor, although NHBE primary cells also expressed ACE2 (Supplementary Figure S1), and so other factors involving the Calu-3 and A549 cancer cell lines, as well as very high ACE2 expression, may also be involved. Here, ACE2 is linked to cancer.